IL6 and melanoma: Additional studies in IL-6 knockout, melanoma-bearing mice demonstrated that a high content of this cytokine in tumor Exo inhibits DC differentiation from monocyte precursors, via a mechanism that includes the transcription of kinases upstream and downstream of STAT-3, while inducing tolerance and therefore the escape of melanoma cells from immune system control [14].